NSB
As noted in the volume breakout scan last night, NSB traded $150K yesterday as opposed to $4K the day before.
NSB is developing the "Capaxone Killer", EmtinB, for MS that makes it a target for Teva Pharmaceuticals (which makes $4B/year from Capaxone) and all other large pharma. EmtinB is 30% more effective than Capaxone, and stimulates myelin production more efficiently. Full Report on independent tests coming out today or tomorrow. Also, Professor Yu brought onto scientific board to progress gluacoma study work announced yesterday.
$12M MC and $4M in bank. I have been unashamedly acquiring for the last 1.5 weeks.
21c share price will be $1.00 within this quarter, and ultimately the company will head to $400M ($6.60) and beyond.
Teva has a history of acquisitions at this early stage, and 'Capaxone' is the core pharma product of the entire company.
Golden cross on the daily yesterday, rising Sto and MACD. Oversold on RSI.
Nothing left below 23c.
You make your own choice, but, this looks good on the charts and the fundos.
Beginning of the rerate this next few days before the bags.
Target in next two sessions, 40c based on resistance channels.
More info here, from a week or so ago:
https://hotcopper.com.au/threads/da...open-july-20.5509108/page-89?post_id=45973310
